TSX:AH • CA01444Q1046
The current stock price of AH.CA is 0.02 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -71.43%.
ChartMill assigns a fundamental rating of 2 / 10 to AH.CA. AH.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AH.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 79.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.
For the next year, analysts expect an EPS growth of 40% and a revenue growth 51.58% for AH.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.39 | 3.019B | ||
| CRON | CRONOS GROUP INC | 36.99 | 1.372B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.213B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.31 | 923.524M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.43 | 686.119M | ||
| GUD | KNIGHT THERAPEUTICS INC | 132.15 | 625.948M | ||
| WEED | CANOPY GROWTH CORP | N/A | 597.979M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 458.223M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 28.02 | 381.475M | ||
| TSND | TERRASCEND CORP | N/A | 304.466M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find more growth stocks the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.
Aleafia Health Inc
85 Basaltic Road
Concord ONTARIO L4K 1G4 CA
CEO: Geoffrey M. Benic
Employees: 158
Phone: 19024054600.0
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.
The current stock price of AH.CA is 0.02 CAD.
AH.CA does not pay a dividend.
AH.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Aleafia Health Inc (AH.CA) operates in the Health Care sector and the Pharmaceuticals industry.
The Revenue of Aleafia Health Inc (AH.CA) is expected to grow by 51.58% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.